Biologic effects and efficacy of Cerebellar tDCS in Children with Autism Spectrum Disorder
Study ID: STU 022017-071
Summary
Please refer to Section 3 of the protocol (Concise Summary of Project).
Participant Eligibility
-Ages 4 to 17, male and female, with known autism spectrum disorder as diagnosed by a clinician -This study may expose unborn children to risks, so females must not be pregnant. Approximately 30 milliliters of urine will be collected from females in the study for a pregnancy test. -- IQ Score no less than 1.5 Standard Deviations below the mean - Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences.)
Please refer to protocol sections [Quote]introduction and Purpose,[Quote] [Quote]Background,[Quote] [Quote]autism and the cerebellum,[Quote] [Quote]non-invasive brain stimulation and autism,[Quote] and [Quote]cerebellar non-invasive stimulation.[Quote]
